肺癌患者使用免疫检查点抑制剂后发生心脏毒性反应的护理

doi:10.3761/j.issn.2096-7446.2025.01.014

中华急危重症护理杂志 ›› 2025, Vol. 6 ›› Issue (1): 86-88.doi: 10.3761/j.issn.2096-7446.2025.01.014

肺癌患者使用免疫检查点抑制剂后发生心脏毒性反应的护理

胡汉(), 冯丹, 何俊峰

310000 杭州市浙江大学医学院附属第二医院护理部

收稿日期:2024-01-30 出版日期:2025-01-10 发布日期:2025-01-14
作者简介:胡汉：女，本科，副主任护师，E-mail：hh157581@zju.edu.cn
基金资助:
浙江省教育厅一般科研项目(自然科学类Y202249636)

Nursing care of cardiotoxic adverse reactions caused by immune checkpoint inhibitors in patients with lung cancer

HU Han(), FENG Dan, HE Junfeng

Received:2024-01-30 Online:2025-01-10 Published:2025-01-14

摘要/Abstract

摘要：

总结3例肺癌患者使用免疫检查点抑制剂治疗后发生心脏毒性反应的护理体会。护理要点：及时评估并监测心脏毒性；安全给药以减轻心脏毒性反应；应用护理多学科协作模式完善专科护理；落实个性化出院随访促进患者早日康复。经及时干预、严密监测和综合管理，1例患者恢复良好，继续行免疫治疗，2例患者停止免疫治疗后行姑息治疗。随访半年，3例患者病情稳定。

关键词: 免疫检查点抑制剂, 心脏毒性, 肺癌, 危重病护理

Abstract:

To summarize the nursing experience of three lung cancer patients with cardiotoxic reactions after treatment with immune checkpoint inhibitors. Key points of care included timely assessment and monitoring of cardiotoxicity，safe drug administration to reduce cardiotoxic reactions，application of multidisciplinary nursing cooperation model to improve specialized nursing，implementing personalized discharge follow-up to promote early recovery of patients. After timely intervention，close monitoring and comprehensive management，one patient recovered well and continued immunotherapy，and two patients were treated with palliative therapy after stopping immunotherapy. The condition of three patients in this group was stable during six-month follow-up.

Key words: Immune Checkpoint Inhibitors, Cardiotoxicity, Lung Cancer, Critical Care Nursing

胡汉, 冯丹, 何俊峰. 肺癌患者使用免疫检查点抑制剂后发生心脏毒性反应的护理[J]. 中华急危重症护理杂志, 2025, 6(1): 86-88.

HU Han, FENG Dan, HE Junfeng. Nursing care of cardiotoxic adverse reactions caused by immune checkpoint inhibitors in patients with lung cancer[J]. Chinese Journal of Emergency and Critical Care Nursing, 2025, 6(1): 86-88.

参考文献 9

[1]	周彩存, 王洁, 步宏, 等. 中国非小细胞肺癌免疫检查点抑制剂治疗专家共识(2019年版)[J]. 中国肺癌杂志, 2020, 23(2):65-76.
	Zhou CC, Wang J, Bu H, et al. Chinese experts consensus on immune checkpoint inhibitors for non-small cell lung cancer(2019 version)[J]. Chin J Lung Cancer, 2020, 23(2):65-76.
[2]	中华医学会呼吸病学分会肺癌学组. 免疫检查点抑制剂相关肺炎诊治专家共识[J]. 中华结核和呼吸杂志, 2019, 42(11):820-825.
	Lung Cancer Group of Respiratory Branch of Chinese Medical Association. Expert consensus on the diagnosis and treatment of pneumonia related to immune checkpoint inhibitors[J]. Chin J Tubere Respir Dis, 2019, 42(11):820-825.
[3]	孙涛. 2023版CSCO肿瘤心脏病学指南中化疗及免疫治疗心脏毒性的更新要点解读[J]. 实用肿瘤杂志, 2023, 38(5):434-439.
	Sun T. Interpretation of updates of 2023 CSCO guidelines for oncology cardiology:chemotherapy and immunotherapy section[J]. J Pract Oncol, 2023, 38(5):434-439.
[4]	Kennedy LC, Wong KM, Kamat NV, et al. Untangling the multidisciplinary care web:streamlining care through an immune-related adverse events(IRAE) tumor board[J]. Target Oncol, 2020, 15(4):541-548. doi: 10.1007/s11523-020-00739-5 pmid: 32710246
[5]	Swami U, Monga V, Bossler AD, et al. Durable clinical benefit in patients with advanced cutaneous melanoma after discontinuation of anti-PD-1 therapies due to immune-related adverse events[J]. J Oncol, 2019,2019:1856594.
[6]	Salem JE, Manouchehri A, Bretagne M, et al. Cardiovascular toxicities associated with ibrutinib[J]. J Am Coll Cardiol, 2019, 74(13):1667-1678.
[7]	段磊, 胡宝祥, 司继刚. 糖皮质激素冲击治疗引发的不良反应及对策[J]. 儿科药学杂志, 2018, 24(1):51-53.
	Duan L, Hu BX, Si JG. Adverse reactions and strategies of glucocorticoid impulse therapy[J]. J Pediatr Pharm, 2018, 24(1):51-53.
[8]	江淑芬, 董畅, 刘莹, 等. 免疫检查点抑制剂相关心血管不良反应的机制、临床表现及管理[J]. 中华心血管病杂志, 2021, 49(4):410-413.
	Jiang SF, Dong C, Liu Y, et al. Mechanism,clinical manifestations and management of cardiovascular adverse reactions associated with immune checkpoint inhibitors[J]. Chin J Cardiol, 2021, 49(4):410-413. doi: 10.3760/cma.j.cn112148-20200501-00364 pmid: 33874697
[9]	Ederhy S, Voisin AL, Champiat S. Myocarditis with immune check-point blockade[J]. N Engl J Med, 2017, 376(3):290-291.

[1]	潘银芝, 杨旻斐. 肝糖原累积病合并脓毒症伴冷凝集现象患者的护理[J]. 中华急危重症护理杂志, 2025, 6(2): 201-203.
[2]	王海燕, 董梦, 祁学峰, 蒋小青, 李婷. 视神经脊髓炎谱系疾病极后区综合征并发呼吸抑制患者的护理[J]. 中华急危重症护理杂志, 2025, 6(2): 204-206.
[3]	杨静, 刘欢, 杜爱平, 尹万红, 田永明. 复杂弥漫性颈部动静脉畸形累及气道致拔管困难患者的护理[J]. 中华急危重症护理杂志, 2025, 6(2): 207-209.
[4]	徐小英, 叶素娟, 吴秋杭, 乔文博, 高春华. 术后患者发生阿片类药物诱导呼吸抑制的评估及预防研究进展[J]. 中华急危重症护理杂志, 2025, 6(2): 252-256.
[5]	宋亚奇, 钟娟平, 程斐然, 任李媛, 左倩倩, 魏政勇, 豆欣蔓. 低价值护理“去实施化”在危重症领域的研究进展[J]. 中华急危重症护理杂志, 2025, 6(1): 65-69.
[6]	北京市体外生命支持质量控制和改进中心/首都医科大学附属北京安贞医院心脏外科危重症中心. 成人体外膜肺氧合循环辅助护理专家共识[J]. 中华急危重症护理杂志, 2025, 6(1): 70-75.
[7]	陈海莲, 邹双, 李程, 王力涵. 重度主动脉瓣狭窄患者急诊行经导管主动脉瓣置换术的围手术期护理[J]. 中华急危重症护理杂志, 2025, 6(1): 79-81.
[8]	刘翠, 魏丽丽, 李琪, 张丛丛, 张艳, 朱福香, 韩晓婕, 宓龙, 崔晓岭. 体外循环心脏术后危重患者体温信息化管理实践研究[J]. 中华急危重症护理杂志, 2025, 6(1): 89-93.
[9]	国家儿童健康与疾病临床医学研究中心/浙江大学医学院附属儿童医院护理部首都医科大学附属北京儿童医院护理部复旦大学附属儿科医院护理部上海交通大学医学院附属上海儿童医学中心PICU 重庆医科大学附属儿童医院PICU 广州市妇女儿童医学中心急诊科苏州大学附属儿童医院急诊科宁波妇女儿童医院护理部（执笔：诸纪华刘丽丽胡静陈文琼陶怡余碧艳俞珍岑慧萍陈亚茹李帅妮）. 危重症患儿院际安全转运护理专家共识[J]. 中华急危重症护理杂志, 2024, 5(9): 825-829.
[10]	丁锦玲杨蕾沈晓姜霞娟. 肝癌患者免疫治疗后发生免疫性肠炎致脓毒性休克的护理[J]. 中华急危重症护理杂志, 2024, 5(9): 830-833.
[11]	兰旭红郭龙飞彭彩丽蒋由飞汤雪梅张丽琴傅彩虹郑小明周红芳张志刚. 地震伤员气管切开后早期拔管的护理实践[J]. 中华急危重症护理杂志, 2024, 5(9): 837-839.
[12]	李晓艳李帅妮李冉唐晓敏. 肺动脉闭锁根治及体肺侧支融合患儿的术后护理[J]. 中华急危重症护理杂志, 2024, 5(9): 840-842.
[13]	鲍向英曾妃兰美娟. 先天性肺动静脉瘘患儿行双肺移植术的护理[J]. 中华急危重症护理杂志, 2024, 5(9): 843-845.
[14]	闻莉姚晓燕包祺. 肝硬化失代偿期患者皮肤感染致脓毒性休克的护理[J]. 中华急危重症护理杂志, 2024, 5(9): 846-848.
[15]	王金艳李欣. 产科高依赖照护模式的研究进展及启示[J]. 中华急危重症护理杂志, 2024, 5(9): 856-859.

肺癌患者使用免疫检查点抑制剂后发生心脏毒性反应的护理

Nursing care of cardiotoxic adverse reactions caused by immune checkpoint inhibitors in patients with lung cancer

RichHTML

PDF下载

可视化

摘要/Abstract

引用本文

使用本文

参考文献 9

相关文章 15

编辑推荐

Metrics

本文评价